NCT05609448View on ClinicalTrials.gov

MRI-guided Holmium-166 Radioembolization

NAEnrolling by invitationINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 23, 2023

Primary Completion Date

January 31, 2025

Study Completion Date

October 31, 2025

Conditions
Primary Liver CancerNon-Resectable Hepatocellular Carcinoma
Interventions
PROCEDURE

MRI-guided radioembolization

Catheter placement will be performed using fluoroscopy, after which patients are transferred to the MRI scanner, where holmium microspheres are administered based on MRI dosimetry. Thereby, patients get a personalized dose administration.

Trial Locations (1)

6500 HB

RadboudUMC, Nijmegen

All Listed Sponsors
collaborator

Terumo Medical Corporation

INDUSTRY

lead

Radboud University Medical Center

OTHER